首页 | 本学科首页   官方微博 | 高级检索  
检索        

胰激肽原酶对自发性高血压大鼠心肌纤维化及NO含量的影响
引用本文:付军,冷吉燕,杜萍,李颖新,刘补尚.胰激肽原酶对自发性高血压大鼠心肌纤维化及NO含量的影响[J].吉林大学学报(医学版),2006,32(5):826-828.
作者姓名:付军  冷吉燕  杜萍  李颖新  刘补尚
作者单位:吉林大学第一医院干部病房,吉林,长春,130021;吉林大学第一医院干部病房,吉林,长春,130021;吉林大学第一医院干部病房,吉林,长春,130021;吉林大学第一医院干部病房,吉林,长春,130021;吉林大学第一医院干部病房,吉林,长春,130021
摘    要:目的:探讨胰激肽原酶对自发性高血压大鼠(SHR)血压、心肌纤维化及血清一氧化氮(NO)含量的影响。方法:雄性15周龄SHR 24只,随机分成SHR组、胰激肽原酶组和卡托普利组,每组8只,另取8只雄性15周龄Wistar大鼠作为正常血压对照组。胰激肽原酶组腹腔注射(7.2 U?kg-1?d-1),卡托普利组灌胃给药(10 mg?kg-1?d-1),SHR组和正常血压对照组给0.9% NaCl溶液腹腔注射(2 mL?kg-1?d-1),各组均连续4周给药。实验4周后行颈动脉插管测量血压,然后处死动物,测量各组左心室重量指数(LVMI)、心肌胶原体积比例(CVF)、心肌血管周围胶原与管腔面积的比例(PVCA)及血清NO含量。结果:SHR组SBP、LVMI、CVF、PVCA增高,血清NO含量下降,与正常血压对照组比较差异均具有显著性(P<0.05)。用药4周后,胰激肽原酶组SBP、LVMI、CVF及PVCA均较SHR组显著下降,两组比较差异均具有显著性(P<0.05);胰激肽原酶组NO含量明显升高且接近正常血压对照组水平;胰激肽原酶组除SBP外的各项指标与卡托普利组比较差异均无显著性(P>0.05)。结论:胰激肽原酶具有降低SHR血压和逆转心肌纤维化的作用,其机制可能与增加NO含量有关。

关 键 词:胰激肽/治疗应用  一氧化氮  心内膜心肌纤维化  大鼠  近交SHR
文章编号:1671-587X(2006)05-0826-03
收稿时间:2006-03-09
修稿时间:2006年3月9日

Effects of pancreatic kininogenase on myocardical fibrosis and serum nitric oxide level in spontaneously hypertensive rats
FU Jun,LENG Ji-yan,DU Ping,LI Ying-xin,LIU Bu-shang.Effects of pancreatic kininogenase on myocardical fibrosis and serum nitric oxide level in spontaneously hypertensive rats[J].Journal of Jilin University: Med Ed,2006,32(5):826-828.
Authors:FU Jun  LENG Ji-yan  DU Ping  LI Ying-xin  LIU Bu-shang
Institution:Department of Cadre Ward,First Hospital,Jinlin University, Changchun 130021, China
Abstract:Objective To investigate the effects of pancreatic kininogenase on pressure,myocardical fibrosis and serum nitric oxide (NO) level in spontaneously hypertensive rats (SHR). Methods Twenty-four (fifteen weeks) male SHR were randomly divided into three groups:SHR group,pancreatic kininogenase group and captopril group(n=8 ),8 male Wistar kyoto rats with normal blood pressure were considered as control group. Pancreatic kininogenase was given by peritoneal injection (7.2 U·kg~ -1 ·d~ -1 ), captopril was given by intragastric administration(10 mg·kg~ -1 ·d~ -1 ), the rats in SHR group and rats with normol blood pressure in control group were treated with 0.9% NaCl(2 mL·kg~ -1 ·d~ -1 )administered through peritoneal injection. After four-week experiment, the pressure was measured in rats througth carotid artery,then the rats were sacrificed , and LVMI,CVF,PVCA and serum NO level were measured. Results In SHR group, SBP,LVMI,CVF and PVCA were higher, serum NO level was decreased obviously than those in control group (P<0.05). After treatment of pancreatic kininogenase,the serum NO level raised obviously,other indexes obviously reduced than those in SHR group (P<0.05),but except SBP,there were no significant difference compared with captopril group (P>0.05). Conclusion Pancreatic kininogenase can obviously reduce the blood pressure and reverse myocardial fibrosis,its mechanism may be concerned with the increasing of NO level in SHR.
Keywords:kallidin/therapeutical use  nitric oxide  endomyocardial fibrosis  rats  inbred SHR
本文献已被 CNKI 万方数据 等数据库收录!
点击此处可从《吉林大学学报(医学版)》浏览原始摘要信息
点击此处可从《吉林大学学报(医学版)》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号